Global Clinical Trial Packaging Market by End User (Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities), by Packaging Type (Vials & Ampoules, Bags & Pouches, Bottles, Syringes, Blisters), by Material Type (Corrugated Fiber, Plastic, Metal, Glass, Paper) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Clinical Trial Packaging Market research report which is segmented by End User (Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities), by Packaging Type (Vials & Ampoules, Bags & Pouches, Bottles, Syringes, Blisters), by Material Type (Corrugated Fiber, Plastic, Metal, Glass, Paper), By Players/Companies Westrock Company, Almac Group Limited, Fisher Clinical Services, Xerimis Inc, Piramal Enterprises Ltd, Sentry BioPharma Services., The Coghlan Group, NextPharma Technologies, PCI Pharma Services, Bilcare Limited”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Clinical Trial Packaging Market Research Report |
| By End User | Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities |
| By Packaging Type | Vials & Ampoules, Bags & Pouches, Bottles, Syringes, Blisters |
| By Material Type | Corrugated Fiber, Plastic, Metal, Glass, Paper |
| By Companies | Westrock Company, Almac Group Limited, Fisher Clinical Services, Xerimis Inc, Piramal Enterprises Ltd, Sentry BioPharma Services., The Coghlan Group, NextPharma Technologies, PCI Pharma Services, Bilcare Limited |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 247 |
| Number of Tables & Figures | 173 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Clinical Trial Packaging Market Report Segments:
The market is segmented by End User (Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities), by Packaging Type (Vials & Ampoules, Bags & Pouches, Bottles, Syringes, Blisters), by Material Type (Corrugated Fiber, Plastic, Metal, Glass, Paper).
Clinical Trial Packaging Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Clinical Trial Packaging Market
Overview of the regional outlook of the Clinical Trial Packaging Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Clinical Trial Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Clinical Trial Packaging Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Research Laboratories
2. Clinical Research Organizations
3. Drug Manufacturing Facilities
7. By Packaging Type:1. Vials & Ampoules
2. Bags & Pouches
3. Bottles
4. Syringes
5. Blisters
8. By Material Type:1. Corrugated Fiber
2. Plastic
3. Metal
4. Glass
5. Paper
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Clinical Trial Packaging Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trial Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trial Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trial Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trial Packaging Market Size & Forecast, 2018-2028
4.5.1 Clinical Trial Packaging Market Size and Y-o-Y Growth
4.5.2 Clinical Trial Packaging Market Absolute $ Opportunity
Chapter 5 Global Clinical Trial Packaging Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Clinical Trial Packaging Market Size Forecast by End User
5.2.1 Research Laboratories
5.2.2 Clinical Research Organizations
5.2.3 Drug Manufacturing Facilities
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Clinical Trial Packaging Market Analysis and Forecast by Packaging Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Packaging Type
6.1.2 Basis Point Share (BPS) Analysis by Packaging Type
6.1.3 Absolute $ Opportunity Assessment by Packaging Type
6.2 Clinical Trial Packaging Market Size Forecast by Packaging Type
6.2.1 Vials & Ampoules
6.2.2 Bags & Pouches
6.2.3 Bottles
6.2.4 Syringes
6.2.5 Blisters
6.3 Market Attractiveness Analysis by Packaging Type
Chapter 7 Global Clinical Trial Packaging Market Analysis and Forecast by Material Type
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Material Type
7.1.2 Basis Point Share (BPS) Analysis by Material Type
7.1.3 Absolute $ Opportunity Assessment by Material Type
7.2 Clinical Trial Packaging Market Size Forecast by Material Type
7.2.1 Corrugated Fiber
7.2.2 Plastic
7.2.3 Metal
7.2.4 Glass
7.2.5 Paper
7.3 Market Attractiveness Analysis by Material Type
Chapter 8 Global Clinical Trial Packaging Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Clinical Trial Packaging Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Clinical Trial Packaging Analysis and Forecast
10.1 Introduction
10.2 North America Clinical Trial Packaging Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Clinical Trial Packaging Market Size Forecast by End User
10.6.1 Research Laboratories
10.6.2 Clinical Research Organizations
10.6.3 Drug Manufacturing Facilities
10.7 Basis Point Share (BPS) Analysis by End User
10.8 Absolute $ Opportunity Assessment by End User
10.9 Market Attractiveness Analysis by End User
10.10 North America Clinical Trial Packaging Market Size Forecast by Packaging Type
10.10.1 Vials & Ampoules
10.10.2 Bags & Pouches
10.10.3 Bottles
10.10.4 Syringes
10.10.5 Blisters
10.11 Basis Point Share (BPS) Analysis by Packaging Type
10.12 Absolute $ Opportunity Assessment by Packaging Type
10.13 Market Attractiveness Analysis by Packaging Type
10.14 North America Clinical Trial Packaging Market Size Forecast by Material Type
10.14.1 Corrugated Fiber
10.14.2 Plastic
10.14.3 Metal
10.14.4 Glass
10.14.5 Paper
10.15 Basis Point Share (BPS) Analysis by Material Type
10.16 Absolute $ Opportunity Assessment by Material Type
10.17 Market Attractiveness Analysis by Material Type
Chapter 11 Europe Clinical Trial Packaging Analysis and Forecast
11.1 Introduction
11.2 Europe Clinical Trial Packaging Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Clinical Trial Packaging Market Size Forecast by End User
11.6.1 Research Laboratories
11.6.2 Clinical Research Organizations
11.6.3 Drug Manufacturing Facilities
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 Europe Clinical Trial Packaging Market Size Forecast by Packaging Type
11.10.1 Vials & Ampoules
11.10.2 Bags & Pouches
11.10.3 Bottles
11.10.4 Syringes
11.10.5 Blisters
11.11 Basis Point Share (BPS) Analysis by Packaging Type
11.12 Absolute $ Opportunity Assessment by Packaging Type
11.13 Market Attractiveness Analysis by Packaging Type
11.14 Europe Clinical Trial Packaging Market Size Forecast by Material Type
11.14.1 Corrugated Fiber
11.14.2 Plastic
11.14.3 Metal
11.14.4 Glass
11.14.5 Paper
11.15 Basis Point Share (BPS) Analysis by Material Type
11.16 Absolute $ Opportunity Assessment by Material Type
11.17 Market Attractiveness Analysis by Material Type
Chapter 12 Asia Pacific Clinical Trial Packaging Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Clinical Trial Packaging Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Clinical Trial Packaging Market Size Forecast by End User
12.6.1 Research Laboratories
12.6.2 Clinical Research Organizations
12.6.3 Drug Manufacturing Facilities
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Asia Pacific Clinical Trial Packaging Market Size Forecast by Packaging Type
12.10.1 Vials & Ampoules
12.10.2 Bags & Pouches
12.10.3 Bottles
12.10.4 Syringes
12.10.5 Blisters
12.11 Basis Point Share (BPS) Analysis by Packaging Type
12.12 Absolute $ Opportunity Assessment by Packaging Type
12.13 Market Attractiveness Analysis by Packaging Type
12.14 Asia Pacific Clinical Trial Packaging Market Size Forecast by Material Type
12.14.1 Corrugated Fiber
12.14.2 Plastic
12.14.3 Metal
12.14.4 Glass
12.14.5 Paper
12.15 Basis Point Share (BPS) Analysis by Material Type
12.16 Absolute $ Opportunity Assessment by Material Type
12.17 Market Attractiveness Analysis by Material Type
Chapter 13 Latin America Clinical Trial Packaging Analysis and Forecast
13.1 Introduction
13.2 Latin America Clinical Trial Packaging Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Clinical Trial Packaging Market Size Forecast by End User
13.6.1 Research Laboratories
13.6.2 Clinical Research Organizations
13.6.3 Drug Manufacturing Facilities
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Latin America Clinical Trial Packaging Market Size Forecast by Packaging Type
13.10.1 Vials & Ampoules
13.10.2 Bags & Pouches
13.10.3 Bottles
13.10.4 Syringes
13.10.5 Blisters
13.11 Basis Point Share (BPS) Analysis by Packaging Type
13.12 Absolute $ Opportunity Assessment by Packaging Type
13.13 Market Attractiveness Analysis by Packaging Type
13.14 Latin America Clinical Trial Packaging Market Size Forecast by Material Type
13.14.1 Corrugated Fiber
13.14.2 Plastic
13.14.3 Metal
13.14.4 Glass
13.14.5 Paper
13.15 Basis Point Share (BPS) Analysis by Material Type
13.16 Absolute $ Opportunity Assessment by Material Type
13.17 Market Attractiveness Analysis by Material Type
Chapter 14 Middle East & Africa (MEA) Clinical Trial Packaging Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by End User
14.6.1 Research Laboratories
14.6.2 Clinical Research Organizations
14.6.3 Drug Manufacturing Facilities
14.7 Basis Point Share (BPS) Analysis by End User
14.8 Absolute $ Opportunity Assessment by End User
14.9 Market Attractiveness Analysis by End User
14.10 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Packaging Type
14.10.1 Vials & Ampoules
14.10.2 Bags & Pouches
14.10.3 Bottles
14.10.4 Syringes
14.10.5 Blisters
14.11 Basis Point Share (BPS) Analysis by Packaging Type
14.12 Absolute $ Opportunity Assessment by Packaging Type
14.13 Market Attractiveness Analysis by Packaging Type
14.14 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Material Type
14.14.1 Corrugated Fiber
14.14.2 Plastic
14.14.3 Metal
14.14.4 Glass
14.14.5 Paper
14.15 Basis Point Share (BPS) Analysis by Material Type
14.16 Absolute $ Opportunity Assessment by Material Type
14.17 Market Attractiveness Analysis by Material Type
Chapter 15 Competition Landscape
15.1 Clinical Trial Packaging Market: Competitive Dashboard
15.2 Global Clinical Trial Packaging Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Westrock Company
15.3.2 Almac Group Limited
15.3.3 Fisher Clinical Services
15.3.4 Xerimis Inc
15.3.5 Piramal Enterprises Ltd
15.3.6 Sentry BioPharma Services.
15.3.7 The Coghlan Group
15.3.8 NextPharma Technologies
15.3.9 PCI Pharma Services
15.3.10 Bilcare Limited
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trial Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trial Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trial Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trial Packaging Market Size & Forecast, 2018-2028
4.5.1 Clinical Trial Packaging Market Size and Y-o-Y Growth
4.5.2 Clinical Trial Packaging Market Absolute $ Opportunity
Chapter 5 Global Clinical Trial Packaging Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Clinical Trial Packaging Market Size Forecast by End User
5.2.1 Research Laboratories
5.2.2 Clinical Research Organizations
5.2.3 Drug Manufacturing Facilities
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Clinical Trial Packaging Market Analysis and Forecast by Packaging Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Packaging Type
6.1.2 Basis Point Share (BPS) Analysis by Packaging Type
6.1.3 Absolute $ Opportunity Assessment by Packaging Type
6.2 Clinical Trial Packaging Market Size Forecast by Packaging Type
6.2.1 Vials & Ampoules
6.2.2 Bags & Pouches
6.2.3 Bottles
6.2.4 Syringes
6.2.5 Blisters
6.3 Market Attractiveness Analysis by Packaging Type
Chapter 7 Global Clinical Trial Packaging Market Analysis and Forecast by Material Type
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Material Type
7.1.2 Basis Point Share (BPS) Analysis by Material Type
7.1.3 Absolute $ Opportunity Assessment by Material Type
7.2 Clinical Trial Packaging Market Size Forecast by Material Type
7.2.1 Corrugated Fiber
7.2.2 Plastic
7.2.3 Metal
7.2.4 Glass
7.2.5 Paper
7.3 Market Attractiveness Analysis by Material Type
Chapter 8 Global Clinical Trial Packaging Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Clinical Trial Packaging Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Clinical Trial Packaging Analysis and Forecast
10.1 Introduction
10.2 North America Clinical Trial Packaging Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Clinical Trial Packaging Market Size Forecast by End User
10.6.1 Research Laboratories
10.6.2 Clinical Research Organizations
10.6.3 Drug Manufacturing Facilities
10.7 Basis Point Share (BPS) Analysis by End User
10.8 Absolute $ Opportunity Assessment by End User
10.9 Market Attractiveness Analysis by End User
10.10 North America Clinical Trial Packaging Market Size Forecast by Packaging Type
10.10.1 Vials & Ampoules
10.10.2 Bags & Pouches
10.10.3 Bottles
10.10.4 Syringes
10.10.5 Blisters
10.11 Basis Point Share (BPS) Analysis by Packaging Type
10.12 Absolute $ Opportunity Assessment by Packaging Type
10.13 Market Attractiveness Analysis by Packaging Type
10.14 North America Clinical Trial Packaging Market Size Forecast by Material Type
10.14.1 Corrugated Fiber
10.14.2 Plastic
10.14.3 Metal
10.14.4 Glass
10.14.5 Paper
10.15 Basis Point Share (BPS) Analysis by Material Type
10.16 Absolute $ Opportunity Assessment by Material Type
10.17 Market Attractiveness Analysis by Material Type
Chapter 11 Europe Clinical Trial Packaging Analysis and Forecast
11.1 Introduction
11.2 Europe Clinical Trial Packaging Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Clinical Trial Packaging Market Size Forecast by End User
11.6.1 Research Laboratories
11.6.2 Clinical Research Organizations
11.6.3 Drug Manufacturing Facilities
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 Europe Clinical Trial Packaging Market Size Forecast by Packaging Type
11.10.1 Vials & Ampoules
11.10.2 Bags & Pouches
11.10.3 Bottles
11.10.4 Syringes
11.10.5 Blisters
11.11 Basis Point Share (BPS) Analysis by Packaging Type
11.12 Absolute $ Opportunity Assessment by Packaging Type
11.13 Market Attractiveness Analysis by Packaging Type
11.14 Europe Clinical Trial Packaging Market Size Forecast by Material Type
11.14.1 Corrugated Fiber
11.14.2 Plastic
11.14.3 Metal
11.14.4 Glass
11.14.5 Paper
11.15 Basis Point Share (BPS) Analysis by Material Type
11.16 Absolute $ Opportunity Assessment by Material Type
11.17 Market Attractiveness Analysis by Material Type
Chapter 12 Asia Pacific Clinical Trial Packaging Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Clinical Trial Packaging Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Clinical Trial Packaging Market Size Forecast by End User
12.6.1 Research Laboratories
12.6.2 Clinical Research Organizations
12.6.3 Drug Manufacturing Facilities
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Asia Pacific Clinical Trial Packaging Market Size Forecast by Packaging Type
12.10.1 Vials & Ampoules
12.10.2 Bags & Pouches
12.10.3 Bottles
12.10.4 Syringes
12.10.5 Blisters
12.11 Basis Point Share (BPS) Analysis by Packaging Type
12.12 Absolute $ Opportunity Assessment by Packaging Type
12.13 Market Attractiveness Analysis by Packaging Type
12.14 Asia Pacific Clinical Trial Packaging Market Size Forecast by Material Type
12.14.1 Corrugated Fiber
12.14.2 Plastic
12.14.3 Metal
12.14.4 Glass
12.14.5 Paper
12.15 Basis Point Share (BPS) Analysis by Material Type
12.16 Absolute $ Opportunity Assessment by Material Type
12.17 Market Attractiveness Analysis by Material Type
Chapter 13 Latin America Clinical Trial Packaging Analysis and Forecast
13.1 Introduction
13.2 Latin America Clinical Trial Packaging Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Clinical Trial Packaging Market Size Forecast by End User
13.6.1 Research Laboratories
13.6.2 Clinical Research Organizations
13.6.3 Drug Manufacturing Facilities
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Latin America Clinical Trial Packaging Market Size Forecast by Packaging Type
13.10.1 Vials & Ampoules
13.10.2 Bags & Pouches
13.10.3 Bottles
13.10.4 Syringes
13.10.5 Blisters
13.11 Basis Point Share (BPS) Analysis by Packaging Type
13.12 Absolute $ Opportunity Assessment by Packaging Type
13.13 Market Attractiveness Analysis by Packaging Type
13.14 Latin America Clinical Trial Packaging Market Size Forecast by Material Type
13.14.1 Corrugated Fiber
13.14.2 Plastic
13.14.3 Metal
13.14.4 Glass
13.14.5 Paper
13.15 Basis Point Share (BPS) Analysis by Material Type
13.16 Absolute $ Opportunity Assessment by Material Type
13.17 Market Attractiveness Analysis by Material Type
Chapter 14 Middle East & Africa (MEA) Clinical Trial Packaging Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by End User
14.6.1 Research Laboratories
14.6.2 Clinical Research Organizations
14.6.3 Drug Manufacturing Facilities
14.7 Basis Point Share (BPS) Analysis by End User
14.8 Absolute $ Opportunity Assessment by End User
14.9 Market Attractiveness Analysis by End User
14.10 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Packaging Type
14.10.1 Vials & Ampoules
14.10.2 Bags & Pouches
14.10.3 Bottles
14.10.4 Syringes
14.10.5 Blisters
14.11 Basis Point Share (BPS) Analysis by Packaging Type
14.12 Absolute $ Opportunity Assessment by Packaging Type
14.13 Market Attractiveness Analysis by Packaging Type
14.14 Middle East & Africa (MEA) Clinical Trial Packaging Market Size Forecast by Material Type
14.14.1 Corrugated Fiber
14.14.2 Plastic
14.14.3 Metal
14.14.4 Glass
14.14.5 Paper
14.15 Basis Point Share (BPS) Analysis by Material Type
14.16 Absolute $ Opportunity Assessment by Material Type
14.17 Market Attractiveness Analysis by Material Type
Chapter 15 Competition Landscape
15.1 Clinical Trial Packaging Market: Competitive Dashboard
15.2 Global Clinical Trial Packaging Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Westrock Company
15.3.2 Almac Group Limited
15.3.3 Fisher Clinical Services
15.3.4 Xerimis Inc
15.3.5 Piramal Enterprises Ltd
15.3.6 Sentry BioPharma Services.
15.3.7 The Coghlan Group
15.3.8 NextPharma Technologies
15.3.9 PCI Pharma Services
15.3.10 Bilcare Limited
Segments Covered in the Report
The global Clinical Trial Packaging market has been segmented based on
By End User
The global Clinical Trial Packaging market has been segmented based on
By End User
- Research Laboratories
- Clinical Research Organizations
- Drug Manufacturing Facilities
- Vials & Ampoules
- Bags & Pouches
- Bottles
- Syringes
- Blisters
- Corrugated Fiber
- Plastic
- Metal
- Glass
- Paper
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Westrock Company
- Almac Group Limited
- Fisher Clinical Services
- Xerimis Inc
- Piramal Enterprises Ltd
- Sentry BioPharma Services.
- The Coghlan Group
- NextPharma Technologies
- PCI Pharma Services
- Bilcare Limited
Related Reports
Some other reports from this category!
